HTG Molecular Diagnostics

HTG Molecular Diagnostics EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HTG Molecular Diagnostics (HTGMQ) as of Nov 4, 2026 is -20.83 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -17.82 M USD — a change of 16.86% (lower).

EBITDA

-20.83 MUSD

YoY

16.86%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HTG Molecular Diagnostics is 2022 -20.83 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HTG Molecular Diagnostics was 2021 -17.82 M USD. It decreases by 16.86% lower compared to the previous year.

The HTG Molecular Diagnostics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2015
-18.89 M USD
Jan 1, 2016
-24.33 M USD
Jan 1, 2017
-17.72 M USD
Jan 1, 2018
-16.16 M USD
Jan 1, 2019
-18.96 M USD
Jan 1, 2020
-19.59 M USD
Jan 1, 2021
-17.82 M USD
Jan 1, 2022
-20.83 M USD
The HTG Molecular Diagnostics EBITDA history
YEAREBITDAYoY
-20.83 MUSD+16.86%
-17.82 MUSD-9.00%
-19.59 MUSD+3.30%
-18.96 MUSD+17.33%
-16.16 MUSD-8.82%
-17.72 MUSD-27.16%
-24.33 MUSD+28.80%
-18.89 MUSD+47.02%
-12.85 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HTG Molecular Diagnostics Stock analysis

What does HTG Molecular Diagnostics do? HTG Molecular Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HTG Molecular Diagnostics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HTG Molecular Diagnostics is -20.83 M USD in 2022.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of HTG Molecular Diagnostics changed from -17.82 M USD to -20.83 M USD, representing a 16.86% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) HTG Molecular Diagnostics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s HTG Molecular Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — HTG Molecular Diagnostics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — HTG Molecular Diagnostics